Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.340 | 0.500 | 0.160 |
Stocks | 99.660 | 99.660 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.874 | 19.037 |
Price to Book | 2.993 | 4.009 |
Price to Sales | 3.711 | 4.718 |
Price to Cash Flow | 14.221 | 15.560 |
Dividend Yield | 1.118 | 0.479 |
5 Years Earnings Growth | 7.588 | 11.115 |
Number of long holdings: 106
Number of short holdings: 25
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alnylam | US02043Q1076 | 3.31 | 150.06 | +1.56% | |
Vertex | US92532F1003 | 3.18 | 446.88 | -2.20% | |
Amgen | US0311621009 | 3.12 | 300.19 | -1.85% | |
Novartis | CH0012005267 | 3.08 | 90.84 | -0.30% | |
Biomarin Pharma | US09061G1013 | 3.04 | 74.43 | -1.44% | |
Ionis Pharma | US4622221004 | 3.02 | 37.64 | +0.97% | |
Gilead | US3755581036 | 3.02 | 63.94 | -2.65% | |
Biogen | US09062X1037 | 2.97 | 218.73 | +0.42% | |
Roche Holding Participation | CH0012032048 | 2.96 | 230.50 | +0.74% | |
Crispr Therapeutics | CH0334081137 | 2.91 | 54.84 | -0.72% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Income Fund C div USD hedged | 16.69B | 0.62 | 2.00 | 4.30 | ||
JPI Global Income Fund C dist USD h | 16.69B | 0.62 | 1.99 | 4.25 | ||
JPI Global Income Fund A acc USD he | 16.69B | 0.77 | 0.22 | 3.48 | ||
JPI Global Income Fund A div USD he | 16.69B | 0.78 | 0.24 | 3.49 | ||
JPI Global Income Fund A mth USD he | 16.69B | 0.76 | 0.21 | 3.46 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review